Logo
BioRePeelCl3 FND Chemical Peel (5 x 6 ml)

BioRePeelCl3 FND Chemical Peel (5 x 6 ml)

BioRePeel

Professional chemical peel
  • CE Marked medical device (BioRePeelCl3 FND and BODY) under applicable European medical device regulations
  • Manufactured in Italy by CMed Aesthetics S.r.l. in compliance with medical device quality Management standards (including ISO 13485 Aligned processes)
  • Classified and labelled for professional use only; use must comply with national regulations regarding scope of practice and medical device handling
  • Intended to be used according to the official CMed Aesthetics instructions for use and classic protocol of BioRePeelCl3
Face, neck and d\u00e9colletage TCA peel

Description

BioRePeelCl3 FND Chemical Peel is an innovative, biphasic (two-phase), patented medical device from CMed Aesthetics designed for non-surgical rejuvenation of the face, neck, décolletage and delicate intimate areas. Supplied as a professional pack of 5 x 6 ml vials, it contains 35% trichloroacetic acid (TCA) as the main active, enhanced by a functional blend of α-hydroxy, β-hydroxy and poly-hydroxy acids, amino acids, vitamins and GABA. This combination delivers controlled chemical exfoliation while powerfully stimulating skin replication and biosynthetic processes, counteracting photoaging, fine lines, wrinkles, acne, pigmentation and oxidative damage. Manufactured to pharmaceutical standards, BioRePeelCl3 FND offers biostimulating, revitalising and peeling actions with minimal downtime and without the frost effect associated with more aggressive TCA peels, making it suitable for use throughout the year when applied by trained professionals.

Bnefits

  • Provides deep yet controlled exfoliation with 35% TCA while minimising surface trauma
  • Stimulates skin replication and biosynthetic processes, supporting collagen and elastin production
  • Improves fine lines, wrinkles and early signs of photoaging on face, neck and décolletage
  • Helps treat comedonal and inflammatory acne, blackheads and post-acne marks
  • Reduces skin pigmentation, melasma and uneven tone when used in appropriate protocols
  • Enhances overall skin radiance, smoothness and firmness without significant downtime
  • Biphasic formulation combines exfoliating acids with amino acids, vitamins and GABA for bio-revitalisation and antioxidant protection
  • Lipophilic phase provides filming and moisturising action and helps stabilise TCA against oxidation
  • No needles required and generally well tolerated, with procedures typically completed in 30–45 minutes
  • Can be used year-round on suitable patients with appropriate photoprotection and professional assessment

Indications

  • Dull, inelastic or tired-looking skin on the face, neck and décolletage
  • Fine lines and superficial to moderate wrinkles caused by intrinsic and extrinsic ageing
  • Photoaging and oxidative damage from UV exposure and pollution
  • Acne in the acute and comedonal stages and post-acne scarring on the face and suitable areas
  • Enlarged pores, blackheads and textural irregularities
  • Skin pigmentation disorders including melasma, post-inflammatory hyperpigmentation and uneven tone (within professional judgement)
  • General facial rejuvenation for patients seeking improved texture, tone and radiance with minimal downtime
  • Intimate-area rejuvenation in appropriately selected patients and clinical settings

Composition

  • Trichloroacetic acid (TCA) 35% (primary peeling and biostimulating agent)
  • Lactobionic acid (poly-hydroxy acid)
  • Salicylic acid (beta-hydroxy acid)
  • Tartaric acid (alpha-hydroxy acid)
  • Citric acid (alpha-hydroxy acid)
  • Amino acids: glycine, proline, hydroxyproline, arginine
  • Vitamins: vitamin C (ascorbyl glucoside / ascorbic derivative), vitamin B2 (riboflavin)
  • Gamma-aminobutyric acid (GABA)
  • Lipophilic phase components: squalene, isopropyl myristate (filming and moisturising agents that stabilise the aqueous phase and protect TCA from oxidation)
  • Additional excipients and stabilisers as specified in the full CMed Aesthetics INCI list

Formulation

  • Biphasic (two-phase) topical solution composed of a hydrophilic (yellow) phase and a lipophilic (blue) phase
  • Contains 35% TCA and a total of 14 active ingredients (acids, amino acids, vitamins and GABA)
  • Must be shaken vigorously prior to use until a temporary, homogenous green emulsion is formed
  • Topical medical device for external use only, intended exclusively for professional use by trained medical and aesthetic practitioners

Packaging

  • Professional pack containing 5 glass vials / ampoules of 6 ml each (5 x 6 ml)
  • Each 6 ml vial holds the biphasic BioRePeelCl3 FND solution ready for re-suspension by shaking
  • Compact format designed for efficient storage and dosing across multiple treatments
  • Supplied within the BioReTherapy line packaging from CMed Aesthetics with clear professional-use labelling

Usage

  • For professional use only; treatment must be performed by a suitably trained healthcare or aesthetic practitioner following the official CMed Aesthetics protocol.
  • Thoroughly cleanse and degrease the treatment area (face, neck, décolletage or intimate area) according to clinic protocol and the BioRePeelCl3 instructions for use.
  • Shake the BioRePeelCl3 FND vial vigorously until the hydrophilic and lipophilic phases combine to form a uniform green emulsion.
  • Using a sterile syringe, withdraw the required volume for the area to be treated (typically: face 1.5–2 ml, neck 1–1.5 ml, décolletage 2–2.5 ml, adjusted according to protocol).
  • Apply the solution evenly over the treatment area using gloved fingers or an appropriate applicator, gently massaging until the product is well distributed.
  • Allow the product to act for up to approximately 10 minutes, with contact time adjusted according to skin type, indication and patient tolerance within recommended limits.
  • At the end of the exposure time, remove the peel by wiping with gauze soaked in water (or saline), ensuring all product residues are removed.
  • Apply recommended post-treatment products such as BioReHydra serum and BioReLift cream, or equivalent soothing and hydrating skincare suited to the patient.
  • Standard treatment course: BioRePeelCl3 FND is typically performed every 7–12 days for 4–6 sessions, depending on the indication and clinical judgement.
  • Instruct patients to avoid direct sun exposure, intense heat, vigorous exercise and harsh or exfoliating skincare for several days after treatment, and to use a broad-spectrum sunscreen daily.
  • Always refer to and follow the latest official CMed Aesthetics classic protocol of use and instructions for BioRePeelCl3 FND; do not deviate from approved guidelines.

Contraindications

  • Known allergy or hypersensitivity to trichloroacetic acid, salicylic acid (including aspirin intolerance), lactobionic acid, tartaric acid, citric acid, amino acids, GABA, vitamin C, vitamin B2 or any other component of the formulation
  • Pregnancy and breastfeeding (commonly treated as a contraindication or strong precaution according to local guidance and clinic policy)
  • Active bacterial, viral or fungal infections, including herpes simplex, in the proposed treatment area
  • Open wounds, cuts, abrasions or active bleeding in the treatment area
  • Active inflammatory dermatoses such as uncontrolled eczema, psoriasis, dermatitis or severe rosacea on the treatment zone
  • History of keloid or hypertrophic scarring tendencies, particularly in the facial or neck areas to be treated
  • History or presence of skin cancers or premalignant lesions in the treatment area unless cleared by an appropriate specialist
  • Uncontrolled systemic conditions (e.g. poorly controlled diabetes, significant autoimmune disease) where healing may be impaired, according to the supervising physician
  • Use of systemic isotretinoin within the previous 6–12 months, depending on current clinical guidelines and professional judgement
  • Recent aggressive aesthetic procedures on the same area, such as deep chemical peels, ablative lasers, dermabrasion or deep microneedling, without sufficient recovery time
  • Severe photosensitivity disorders or concurrent use of medications that significantly increase photosensitivity without appropriate precautions
  • Inability or unwillingness to adhere to post-treatment care requirements, including sun protection, avoidance of irritants and adherence to recommended treatment intervals

Adverse Effects

  • Transient burning, stinging, tingling or warmth during and shortly after application
  • Post-treatment erythema (redness) and mild swelling, typically resolving within hours to a few days
  • Sensation of tightness, dryness and varying degrees of flaking or mild desquamation as the outer layers of the stratum corneum shed
  • Temporary increase in sensitivity to skincare products, environmental conditions and UV exposure
  • Potential purging or temporary flare of acne and comedones as congestion is brought to the surface
  • Local irritation, superficial erosions or excessive peeling if contact time, application quantity or skin preparation is inappropriate or if aftercare instructions are not followed
  • Risk of post-inflammatory hyperpigmentation, particularly in higher Fitzpatrick skin types or when patients do not use adequate photoprotection
  • Very rare but possible complications such as infection, scarring or persistent pigmentary changes if contraindications are ignored, technique is poor or the patient fails to comply with aftercare

Storage Conditions

  • Store at controlled room temperature as indicated on the product packaging, away from direct sunlight and sources of heat.
  • Cold storage is not required, but the product should be protected from extreme temperatures and sudden temperature fluctuations.
  • Keep vials in their original outer carton until use to protect them from light and reduce the risk of contamination or mechanical damage.
  • Do not use the product if the vial is damaged, if there are signs of improper storage, or if abnormalities are observed in the biphasic solution that do not resolve with shaking, and never use beyond the expiry date.
  • Follow CMed Aesthetics guidance and local regulations for the safe storage and disposal of chemical peel medical devices and associated consumables.

Duration

In clinical practice, BioRePeelCl3 FND procedures generally take around 30\u201345 minutes per session, including preparation, application, contact time of up to 10 minutes and post-care. A typical course consists of 4\u20136 sessions performed every 7\u201312 days, with results lasting several months depending on the patient\u2019s skin condition, lifestyle and maintenance regimen.

Onset

Many patients notice improvements in skin texture, smoothness and radiance shortly after the first session, with further visible reduction of fine lines, acne lesions and pigmentation irregularities emerging over subsequent treatments. Optimal results usually develop progressively over the full course of 4\u20136 sessions and continue to consolidate over the following weeks as collagen remodelling and cell renewal proceed.

Browse more Professional chemical peel

Top Treatments

Top Cities in the UK